Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KALA BIO, Inc. - Common Stock (NQ:KALA)

0.6580 -0.0685 (-9.43%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about KALA BIO, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Kala Pharmaceuticals Announces EYSUVIS® Now Covered by OptumRx
From Kala Pharmaceuticals, Inc.
Via Business Wire
News headline image
Kala Pharmaceuticals to Present at Jefferies 2021 Virtual Healthcare Conference
From Kala Pharmaceuticals, Inc.
Via Business Wire
News headline image
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Kala Pharmaceuticals, Inc.
Via Business Wire
News headline image
Kala Pharmaceuticals to Present at BofA Securities 2021 Healthcare Conference
From Kala Pharmaceuticals, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
Kala Pharmaceuticals: Q1 Earnings Insights ↗
Shares of Kala Pharmaceuticals (NASDAQ:KALA) fell 0.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 9.26%... 
Via Benzinga
News headline image
Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
From Kala Pharmaceuticals, Inc.
Via Business Wire
News headline image
Kala Pharmaceuticals Earnings Preview ↗
Kala Pharmaceuticals (NASDAQ:KALA) announces its next round of earnings this Wednesday, May 05. Here is Benzinga's everything-that-matters guide for this Wednesday's Q1 earnings... 
Via Benzinga
News headline image
Kala Pharmaceuticals to Report First Quarter 2021 Financial Results and Host Conference Call
From Kala Pharmaceuticals, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.